Dublin, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The "Companion Diagnostic Collaboration and Licensing Deals 2010-2024" report has been added to ResearchAndMarkets.com's offering.
Companion Diagnostic Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the companion diagnostic deals entered into by the world's leading biopharma companies.
Fully revised and updated, the report provides details of companion diagnostic deals from 2010 to 2024. The report provides a detailed understanding and analysis of how and why companies enter companion diagnostic deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. The report includes collaboration, development, research and licensing deals.
This report contains a comprehensive listing of 530 companion diagnostic deals announced since 2010 including financial terms where available including links to online deal records of actual companion diagnostic partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.
In addition, a comprehensive deal directory is provided organized by company A-Z, deal type and therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Companion Diagnostic Collaboration and Licensing Deals includes:
- Trends in companion diagnostic dealmaking in the biopharma industry
- Directory of companion diagnostic deal records covering pharmaceutical and biotechnology
- The leading companion diagnostic deals by value
- Most active companion diagnostic licensing dealmakers
Analyzing contract agreements allows due diligence of:
- What are the precise rights granted or optioned?
- What is actually granted by the agreement to the partner company?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How are sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are IPRs handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes to be resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and subcontracting provisions have been agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement law?
Key Topics Covered:
Executive Summary
Chapter 1 - Introduction
Chapter 2 - Trends in companion diagnostic dealmaking
2.1. Introduction
2.2. Companion diagnostic deals over the years
2.3. Most active companion diagnostic dealmakers
2.4. Companion diagnostic deals by deal type
2.5. Companion diagnostic deals by therapy area
2.6. Companion diagnostic deals by industry sector
2.7. Deal terms for companion diagnostic deals
2.7.1 Companion diagnostic deals headline values
2.7.2 Companion diagnostic deal upfront payments
2.7.3 Companion diagnostic deal milestone payments
2.7.4 Companion diagnostic royalty rates
Chapter 3 - Leading companion diagnostic deals
3.1. Introduction
3.2. Top companion diagnostic deals by value
Chapter 4 - Most active companion diagnostic dealmakers
4.1. Introduction
4.2. Most active companion diagnostic dealmakers
4.3. Most active companion diagnostic deals company profiles
Chapter 5 - Companion diagnostic contracts dealmaking directory
5.1. Introduction
5.2. Companion diagnostic contracts dealmaking directory
Chapter 6 - Companion diagnostic dealmaking by technology type
Deal directory
- Deal directory - Companion diagnostic deals by company A-Z
- Deal directory - Companion diagnostic deals by deal type
- Deal directory - Companion diagnostic deals by therapy area
- Deal type definitions
Select Companies Featured in the Companion Diagnostic Sector Include:
- A2 Biotherapeutics
- Abbisko Therapeutics
- Abbott Laboratories
- Abbvie
- Abcam
- AccuGenomics
- Achaogen
- Acrivon Therapeutics
- ADC Therapeutics
- Adial Pharmaceuticals
- Advaxis
- Aelan Cell Technologies
- AEterna Zentaris
- Affymetrix
- Agilent Technologies
- Agios Pharmaceuticals
- Akili Interactive Labs
- Akoya Biosciences
- Algeta
- Allarity Therapeutics
- Almac Diagnostics
- Almac Group
- Alphageneron Pharmaceuticals
- AltheaDX
- Amarantus BioSciences
- Ambit Biosciences
- Amgen
- Amoy Diagnostics
- AmpliPhi Biosciences
- AmpTec
- Analytics Engines
- AnchorDx
- Angle
- AnHeart Therapeutics
- Apogenix
- Apollomics
- ArcherDX
- Ariad Pharmaceuticals
- ARK Diagnostics
- Array Biopharma
- Arvinas
- Ashvattha Therapeutics
- AssureRx Health
- Astellas Pharma
- AstraZeneca
- Astrimmune
- Asuragen
- Atherotech
- Atlas Antibodies
- Aushon BioSystems
- AVEO Oncology
- Avila Therapeutics
- Bayer
- Bayer Healthcare
- Beckman Coulter
- BeiGene
- Biocare Medical
- Biocartis
- Biocept
- BioChain
- Biodesix
- Biogen
- Biognosys
- BioImagene
- BioMarin Pharmaceutical
- BioMarker Strategies
- Biomedix
- Biomerica
- bioMerieux
- Biomoda
- BiomX
- BioNTech
- BioSkryb
- Biovica
- Blueprint Medicines
- Boehringer Ingelheim
- Bpifrance
- Brenus Pharma
- Bristol-Myers Squibb
- Burning Rock
- Cadila Pharmaceuticals
- Calviri
- Cambridge Biomedical
- Canary Foundation
- Carena
- Caris Life Sciences
- Celgene
- Celladon
- Cellgen Diagnostics
- Cephalon
- Cepheid
- Cernostics
- CHDI Foundation
- Chembio Diagnostics
- Chronix Biomedical
- Chugai Pharmaceutical
- Ci-Co Healthcare
- Clarient
- Clavis Pharma
- Clevexel Pharma
- Clovis Oncology
- CompanDX
- Companion Medical
- Compendia Bioscience
- CStone Pharmaceuticals
- Cynvenio
- Daiichi Sankyo
- Dako
- Debiopharm
- Definiens
- Denovo Biopharma
- DermTech
- DiagnoCure
- DiamiR
- Diaxonhit
- Dimerix Biosciences
- DxS
- Eisai
- Eli Lilly
- Empire Genomics
- Endocyte
- Enterome Bioscience
- Enzo Biochem
- Epigenomics
- Epitomics
- Epizyme
- Erytech Pharma
- Eureka Eurostars
- Eurofins Genomics
- Eutropics Pharmaceuticals
- Evotec
- Exact Sciences
- Exosome Diagnostics
- Ferring Pharmaceuticals
- Fibrocell Science
- FivepHusion
- Five Prime Therapeutics
- Flare Therapeutics
- Foundation Medicine
- Freenome
- Fujirebio Diagnostics
- Fusion Antibodies
- FYR Diagnostics
- Galena Biopharma
- Galmed Pharmaceuticals
- GE Healthcare
- Gemini Therapeutics
- Genentech
- Generex Biotechnology
- Geneseeq
- Genmab
- GenomeDx
- Genomeon
- Genomic Health
- Genomic Testing Cooperative
- Genoptix
- Genosity
- Genzyme
- Gibson Oncology
- GlaxoSmithKline Biologicals
- Glythera
- Golden Helix
- Grail
- GSK
- Guardant Health
- HalioDx
- Halozyme Therapeutics
- Health Discovery
- Helix
- Hengrui Therapeutics
- Henlius Biotech
- HiberCell
- Hoffmann La Roche
- Horizon
- Horizon Discovery
- Horizon Europe
- HotSpot Therapeutics
- Hybrigenics
- I-mab
- Icon
- IDbyDNA
- Idera Pharmaceuticals
- Illumina
- ImaginAb
- Imanis Life Sciences
- IMIDomics
- ImmunID Technologies
- ImmunoCellular Therapeutics
- ImmunoGen
- ImmusanT
- IMPACT Therapeutics
- IncellDx
- Incyte
- Innovate UK
- Inotrem
- Inova Diagnostics
- Inovio Pharmaceuticals
- Inserm Transfert
- Insight Genetics
- InSphero
- IntegraGen
- Intezyne
- Invivis Pharmaceuticals
- InVivoScribe
- Ionis Pharmaceuticals
- Ipsen
- Ipsogen
- IRCCS
- Ironwood Pharmaceuticals
- IRX Therapeutics
- Janssen Biotech
- Jiangsu Hengrui Medicine
- Johnson & Johnson Innovation
- Kalgene Pharmaceuticals
- Kartos Therapeutics
- Karyopharm Therapeutics
- KineMed
- Kiyatec
- Kreatech
- Kronos Bio
- KSB Diagnostics
- Lab21
- Laboratory Corporation of America
- Lantern Pharma
- Leap Therapeutics
- Leica Biosystems
- Leica Microsystems
- Les Laboratoires Servier
- Locus Biosciences
- London Genetics
- Loxo Oncology
- Luminex
- Lumiphore
- LUNGevity Foundation
- Luye Pharma Group
- M42
- Macrogenics
- MapKure
- Mayo Clinic
- MDxHealth
- Med BioGene
- Medicover
- Medivation
- Medx
- Merck and Co
- Merus
- Metamark Genetics
- MetaStat
- Mikrogen
- Millennium
- Miragen Therapeutics
- Mirati Therapeutics
- MolecularMD
- Morphotek
- Multimmune
- Myriad Genetics
- NanoString Technologies
- Navigate BioPharma Services
- Neogenix Oncology
- Neogenomics
- NeuroMetrix
- Neuron23
- Nodality
- Novartis
- Novogene
- Nuclea Biotechnologies
- Nucleai
- NuSirt
- OcellO
- Offspring Biosciences
- On-Q-ity
- Oncoheroes Biosciences
- Oncology Venture
- OncoMed Pharmaceuticals
- OncXerna Therapeutics
- Ono Pharmaceutical
- OPKO Health
- Oridis Biomarkers
- OrigiMed
- Ortho-Clinical Diagnostics
- OSE Immunotherapeutics
- OSEO
- OSI Pharmaceuticals
- Oxford BioMedica
- Oxford Gene Technology
- Paradigm
- PathAI
- Patrys
- PerkinElmer
- Personal Genome Diagnostics
- Personalis
- Pfizer
- Pharmacyclics
- PharmaMar
- Pionyr Immunotherapeutics
- Piramal Imaging
- PMV Pharma
- Precision for Medicine
- Precision Therapeutics
- Predicine
- Primeradx
- Profusa
- Promega
- Prometheus Biosciences
- ProPath
- Protagen
- Puma Biotechnology
- Pure MHC
- Q BioMed
- QED Therapeutics
- QIAGEN
- Quest Diagnostics
- Quintiles
- R-Biopharm
- R-Pharm
- Race Oncology
- Radius Health
- RedHill Biopharma
- Regulus Therapeutics
- Relay Therapeutics
- ResearchDx
- Resolution Bioscience
- Revive Therapeutics
- Roche Diagnostics
- Saladax Biomedical
- Salix Pharmaceuticals
- Sanofi
- Scancell
- Scandion Oncology
- Seattle Genetics
- Seegene
- Sengenics
- Serametrix
- Shuwen Biotech
- Siemens Healthcare
- Singulex
- Sirius Genomics
- Skysong Innovations
- Spectrum Pharmaceuticals
- Splicos
- Spruce Biosciences
- SRL
- Strata Oncology
- SuperNova Diagnostics
- Syapse
- Syndax Pharmaceuticals
- Synthon
- Sysmex
- Sysmex Inostics
- T-Cure Bioscience
- Takeda Pharmaceutical
- Tasly Pharmaceuticals
- Telix Pharmaceuticals
- Tempus
- Tesaro
- Theradiag
- Thermo Fisher Scientific
- Tocagen
- Tokai Pharmaceuticals
- Tolero Pharmaceuticals
- Total Brain
- TP Therapeutics
- TScan Therapeutics
- uBiome
- UCB
- USBiomarkers
- ValiRx
- Van Andel Institute
- Vela Diagnostics
- Ventana Medical Systems
- Veracyte
- Verastem
- Veridex
- VeriSIM Life
- Vertex Pharmaceuticals
- ViiV Healthcare
- ViroMed
- Virovek
- Vyriad
- WAVE Life Sciences
- Whitehead Institute
- WuXi NextCODE Genomics
- XDx
- Xencor
- Xenon Pharmaceuticals
- ZAI Laboratory
- Zinfandel Pharmaceuticals
- Zora Biosciences
For more information about this report visit https://www.researchandmarkets.com/r/6kuzul
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
